Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the RIALTO trial, an expanded access study.

Franco LocatelliGerhard ZugmaierNoemi MergenPeter BaderSima JehaPaul-Gerhardt SchlegelJean-Pierre BourquinRupert HandgretingerBenoit BrethonClaudia RossigChristiane Chen-Santel

Published in: Blood cancer journal (2020)

Keyphrases

acute lymphoblastic leukemia
allogeneic hematopoietic stem cell transplantation
study protocol
phase iii
phase ii
multiple myeloma
open label